Financial results - ARUX PHARMA SRL

Financial Summary - Arux Pharma Srl
Unique identification code: 37672116
Registration number: J40/8112/2017
Nace: 7320
Sales - Ron
29.212
Net Profit - Ron
9.095
Employees
1
Open Account
Company Arux Pharma Srl with Fiscal Code 37672116 recorded a turnover of 2024 of 29.212, with a net profit of 9.095 and having an average number of employees of 1. The company operates in the field of Activităţi de studiere a pieţei şi de sondare a opiniei publice having the NACE code 7320.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Arux Pharma Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - 20.960 15.629 41.827 37.386 40.966 45.024 14.188 29.212
Total Income - EUR - - 21.321 15.633 42.768 38.584 42.109 45.065 14.805 29.230
Total Expenses - EUR - - 4.576 14.005 23.437 13.245 13.637 19.791 29.640 19.848
Gross Profit/Loss - EUR - - 16.745 1.628 19.331 25.340 28.472 25.274 -14.835 9.381
Net Profit/Loss - EUR - - 16.106 1.472 18.903 24.970 28.050 24.833 -14.983 9.095
Employees - - 0 1 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 107.1%, from 14.188 euro in the year 2023, to 29.212 euro in 2024. The Net Profit increased by 9.095 euro, from 0 euro in 2023, to 9.095 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Arux Pharma Srl

Rating financiar

Financial Rating -
ARUX PHARMA SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Arux Pharma Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Arux Pharma Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Arux Pharma Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Arux Pharma Srl - CUI 37672116

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - 12 0 0 0 18 0 0 2.564
Current Assets - - 20.996 23.086 63.364 75.854 96.640 129.051 42.279 44.017
Inventories - - 0 0 0 62 0 67 0 0
Receivables - - 10.919 1.751 4.117 20.127 4.076 276 1.629 9.919
Cash - - 10.077 21.335 59.247 55.665 92.564 128.709 40.650 34.097
Shareholders Funds - - 16.149 17.325 35.893 60.182 86.898 24.882 9.824 18.863
Social Capital - - 44 43 42 41 40 41 40 40
Debts - - 4.876 5.777 27.490 15.693 9.760 104.170 32.456 27.717
Income in Advance - - 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7320 - 7320"
CAEN Financial Year 7320
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 44.017 euro in 2024 which includes Inventories of 0 euro, Receivables of 9.919 euro and cash availability of 34.097 euro.
The company's Equity was valued at 18.863 euro, while total Liabilities amounted to 27.717 euro. Equity increased by 9.095 euro, from 9.824 euro in 2023, to 18.863 in 2024.

Risk Reports Prices

Reviews - Arux Pharma Srl

Comments - Arux Pharma Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.